Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

64.68USD
22 Oct 2014
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$64.68
Open
$64.59
Day's High
$65.28
Day's Low
$64.59
Volume
1,168,870
Avg. Vol
964,844
52-wk High
$67.12
52-wk Low
$48.89

LLY.N

Chart for LLY.N

About

Eli Lilly and Company, discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through facilities in the United States, Puerto Rico, and 15 other countries. Its products are sold... (more)

Overall

Beta: 0.47
Market Cap (Mil.): $72,267.50
Shares Outstanding (Mil.): 1,117.31
Dividend: 0.49
Yield (%): 3.03

Financials

  LLY.N Industry Sector
P/E (TTM): 20.59 32.90 33.54
EPS (TTM): 3.14 -- --
ROI: 12.95 18.34 17.61
ROE: 20.43 19.01 18.42
Search Stocks

Stada secures third license for copycat biotech drug: CEO

BAD VILBEL Germany - Germany's Stada plans to bring a copy of Eli Lilly's Forteo osteoporosis treatment to market, its chief executive said, as the generic drugmaker moves further into the sale of cheaper alternatives for costly biotech drugs.

10 Oct 2014

EU mergers and takeovers (Oct 3)

BRUSSELS, Oct 3 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

03 Oct 2014

EU Commission clears Eli Lilly, Novartis deal

BRUSSELS - EU antitrust regulators approved U.S. drugmaker Eli Lilly's $5.4 billion takeover of Swiss peer Novartis's animal health business on Friday.

03 Oct 2014

EU Commission clears Eli Lilly-Novartis animal health deal

BRUSSELS, Oct 3 - EU antitrust regulators approved U.S. drugmaker Eli Lilly's $5.4 billion takeover of Swiss peer Novartis's animal health business on Friday.

03 Oct 2014

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources

BRUSSELS - EU antitrust regulators will open an extensive probe into Zimmer's $13.4 billion bid for Biomet, concerned that the creation of the world's second-largest orthopedic products group may hurt competition, three people familiar with the matter said on Thursday.

02 Oct 2014

UPDATE 2-EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal - sources

* Zimmer may have to offer concessions to allay EU worries

02 Oct 2014

Eli Lilly stops development of lupus drug; XTL shares soar

- Eli Lilly and Co said it would stop the development of its drug to treat the autoimmune disorder lupus, after it was found to be not effective enough in late-stage trials.

02 Oct 2014

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal - sources

BRUSSELS, Oct 2 - EU antitrust regulators will widen a probe into Zimmer Holdings Inc's $13.4 billion bid for Biomet Inc but clear Eli Lilly's offer for a Novartis AG unit, three people familiar with the matter said on Thursday.

02 Oct 2014

Eli Lilly to drop development of lupus drug

Oct 2 - Eli Lilly and Co said it would discontinue the development of its lupus drug as the treatment was not found to be effective enough in two late-stage trials.

02 Oct 2014

Wall St. climbs as expectations shift on Fed policy

NEW YORK - U.S. stocks rose on Tuesday and the S&P notched its best performance in a month after a report shifted investor expectations for the Federal Reserve's policy statement due on Wednesday.

16 Sep 2014

Competitors

  Price Change
Takeda Pharmaceutical Co Ltd (4502.T) ¥4,486 +4.50
Johnson & Johnson (JNJ.N) $101.22 +0.86
Pfizer Inc. (PFE.N) $28.30 +0.02
Novartis AG (NOVN.VX) CHF84.65 +1.10
Merck & Co., Inc. (MRK.N) $55.51 +0.38
Abbott Laboratories (ABT.N) $41.59 -0.80
Sanofi SA (SASY.PA) €83.43 +1.95
AstraZeneca plc (AZN.L) 4,316.50p +81.00
GlaxoSmithKline plc (GSK.L) 1,377.00p +35.00
Bristol-Myers Squibb Co (BMY.N) $51.84 -0.11

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks